Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005

Journal of Neuro-Oncology

Volumn 101, Issue 1, 2011, Pages 117-123

  Fuentes Raspall, Rafael ^a,b   Vilardell, Loreto ^a,b   Perez Bueno, Ferran ^b   Joly, Carmen ^b   Garcia Gil, Maria ^b   Garcia Velasco, Adelaida ^a   Marcos Gragera, Rafael ^a,b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Incidence; Population based; Primary brain tumours; Survival

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CONTROLLED STUDY; EPENDYMOBLASTOMA; EPENDYMOMA; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NEUROEPITHELIOMA; OBSERVATIONAL STUDY; OLIGODENDROGLIOMA; PRESCHOOL CHILD; SEX DIFFERENCE; SPAIN; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 78651313326     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0240-7     Document Type: Article

References (18)

1. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 1:CAS:528:DC%2BD2MXit1Wksbk%3D 10.1056/NEJMoa043330 15758009
2. JJ Vredenburgh A Desjardins JE Herndon II JM Dowell DA Reardon JA Quinn JN Rich S Sathornsumetee S Gururangan M Wagner DD Bigner AH Friedman HS Friedman 2007 Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma Clin Cancer Res 13 1253 1259 1:CAS:528:DC%2BD2sXhvF2htr8%3D 10.1158/1078-0432.CCR-06-2309 17317837
3. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jääskeläinen Z Ram 2003 A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro Oncol 5 79 88 1:CAS:528:DC%2BD3sXjtVKltL4%3D 12672279
4. JS Barnholtz-Sloan VL Williams JL Maldonado D Shahani HG Stockwell M Chamberlain A Sloan 2008 Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma J Neurosurg 108 642 648 10.3171/JNS/2008/ 108/4/0642 18377240
5. SM Chang IF Parney W Huang FA Anderson AL Asher M Bernstein KO Lillehei MS Brem MS Berger Laws ER for the Glioma Outcomes Project Investigators 2005 Patterns of care for adults with newly diagnosed malignant glioma JAMA 293 557 564 1:CAS:528:DC%2BD2MXhtVWqsL4%3D 10.1001/jama.293.5.557 15687310
6. ML Bondy ME Scheurer B Malmer JS Barnholtz-Sloan FG Davis D Il'yasova C Kruchko DJ McCarthy P Rajaraman JA Schwartzbaum S Sadetzki B Schlehofer T Tihan JL Wiemels M Wrensch PA Buffler Brain Tumor Epidemiology Consortium 2008 Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium Cancer 113 7 Suppl 1953 1968 10.1002/cncr.23741 18798534
7. A Fleury F Menegoz P Grosclaude JP Daures M Henry-Amar N Raverdy P Schaffer M Poisson JY Delattre 1997 Descriptive epidemiology of cerebral gliomas in France Cancer 79 1195 1202 1:STN:280:DyaK2s3itl2itQ%3D%3D 10.1002/(SICI)1097-0142(19970315)79:6<1195::AID-CNCR19>3.0.CO;2-V 9070498
8. A Helseth SJ Mork 1989 Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology Acta Pathol Microbiol Immunol Scand 97 547 555 1:STN:280: DyaL1M3oslSktw%3D%3D
9. P Joensen 1981 Incidence of primary intracranial neoplasms in an isolated population (the Faroese) during the period 1962-1975 Acta Neurol Scand 64 74 78 1:STN:280:DyaL387gvF2qtQ%3D%3D 10.1111/j.1600-0404.1981.tb04387.x 7324874
10. M Kallio 1988 The incidence of intracranial gliomas in southern Finland Acta Neurol Scand 78 480 483 1:STN:280:DyaL1M7jtFKitw%3D%3D 10.1111/j.1600-0404. 1988.tb03691.x 3223235
11. KR Guomundsson 1970 A survey of tumours of the central nervous system in Iceland during the 10-year period 1954-1963 Acta Neurol Scand 46 538 552 1:STN:280:DyaE3M7jslCltw%3D%3D 10.1111/j.1600-0404.1970.tb05811.x 4323342
12. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumors of the central nervous system. IARC Press, Lyon, France
13. R Clèries J Valls L Esteban J Gàlvez L Pareja X Sanz L Alliste JM Martinez V Moreno X Bosch JM Borras JM Ribes 2007 WAERS: an application for Web-assisted estimation of relative survival Med Inform Internet Med 32 169 175 10.1080/14639230601185575 17701823
14. T Hakulinen 1977 On long-term relative survival rates J Chronic Dis 30 431 443 1:STN:280:DyaE2s3ivVWisA%3D%3D 10.1016/0021-9681(77)90036-4 885984
15. Elandt-Johnson RC, Johnson NL (1980) Survival models and data analysis. Wiley, New York
16. A Helseth F Langmark SJ Mork 1988 Neoplasms of the central nervous system in Norway. II. Descriptive epidemiology of intracranial neoplasms 1955-1984 Acta Pathol Microbiol Immunol Scand 96 1066 1074 1:STN:280:DyaL1M7gsFeqsg%3D%3D
17. Bailey P, Cushing H (1926) A classification of the tumours of the glioma group on a histogenic basis with a correlated study of prognosis. Lippincott, Philadelphia
18. JM Kros 2007 From expert opinion to evidence-based: changes in the gold standard of primary brain tumour diagnosis J Pathol 213 1 3 1:CAS:528: DC%2BD2sXhtFSksLrM 10.1002/path.2201 17593567